ETF Financing Ranking | China Universal NASDAQ Biotechnology Technology ETF(QDII) (513290) had a net financing buy-in of CNY 15.29 million, ranked in the first tier of the entire market-20260811
NewTimeSpace (newtimespace.com) News, Aug 11, 2026, China Universal NASDAQ Biotechnology Technology ETF(QDII) (513290.SH) decreased by 0.47%, had a turnover of CNY 166.65 million. Obtained financing buy-in of CNY 28.94 million, and financing repayment of CNY 13.65 million, with a net financing buy-in of CNY 15.29 million, ranked in the first tier of the entire market. (Data source: Wind)
Over a longer period, for the past 5 trading days of the fund, there were 3 days with net financing buy-in, totaling CNY 23.92 million, ranked in the first tier of the entire market. (Data source: Wind)
China Universal NASDAQ Biotechnology Technology ETF(QDII) (513290.SH), off-exchange connection (A type: 017894; C type: 017895).
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CIDI(03881.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 112.56 million, loss narrowed by 75.23% YoY
- JS Global Lifestyle (01691.HK): Expected Net Profit of No Less Than US$12 Million for First Half
- CU VENTURE INV(08159.HK)FY 25/26 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 80.02 million, loss widened by 40.31% YoY